MedTrace Logo

Effect of Peer-mentor Mediated Interventions on Cardiovascular Risk Factors at Worksites

NCT02388542 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2017-09-14

No results posted yet for this study

Summary

The investigators propose conducting a pilot study to identify 6 worksites (2 India, 2 Sri Lanka, 2 Bangladesh) explore barriers to optimum cardiovascular disease(CVD) care at these worksites, quantify risk factor level in worksite populations and identify and train peer mentors to deliver an educational intervention to improve life style and enhance medication adherence among those at moderate to high risk of cardiovascular disease (CVD).

Conditions

Interventions

BEHAVIORAL

Educational Intervention

Employees above the age of 35 years will be risk stratified into moderate or high risk of developing cardiovascular disease using a simple non-lab based risk scoring system, they will be invited to participate in the pilot intervention study. This is a single arm before-after study.subject education will focus on life style medication and adherence to medication (if applicable).importantly the peer mentor will try to identify barriers to adopting a healthy lifestyle(tobacco, physical acitivity, diet, alcohol and strees) and adherence to cardiovascular disease prevention medication. peer mentors will be trained to interpret blood glucose and lipids, recognize abnormal valves, provide lifestyle counseling and refer to treating physician when appropriate.

Sponsors & Collaborators

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    collaborator OTHER

  • University of Colombo

    collaborator OTHER

  • University of Oxford

    collaborator OTHER

  • St. John's Research Institute

    lead OTHER

Principal Investigators

  • Dr Denis Xavier, M.D,MSc. · St.John's Medical College

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-10-31
Completion
2017-12-31

Countries

  • Bangladesh
  • India
  • Sri Lanka

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02388542 on ClinicalTrials.gov